Scalp-cooling Device May Reduce Hair Loss in Breast Cancer Chemotherapy Patients

Scalp-cooling Device May Reduce Hair Loss in Breast Cancer Chemotherapy Patients
While it may not be the most serious side effect associated with breast cancer chemotherapy, hair loss can be one of the most traumatic — especially for female patients. "Hair loss takes a tremendous toll on the patient's body image, and they no longer have the anonymity of hiding the disease; everyone can see that they're sick," Julie Rani Nangia, MD, an assistant professor of medicine at Baylor College of Medicine's Lester and Sue Smith Breast Center, said in a press release. "Patients and physicians have been hoping and searching for methods or therapies to prevent or reduce hair loss due to chemotherapy, but the options have been very limited due to the complexity of both the disease and the treatment," she added. Nangia, who is board certified in internal medicine and medical oncology, has a special interest in hereditary breast cancer, breast cancer prevention, and metastatic triple negative breast cancer, and is familiar with the psychological effects that hair loss has on her patients. Now, a new proprietary scalp cooling cap technology may help reduce hair loss in breast cancer patients who are undergoing taxane or anthracycline chemotherapy. The Orbis Paxman Hair Loss Prevention System is the subject of a clinical study currently underway led by scientists at Baylor and being conducted at seven trial sites across the country. Its results were recently presented at the 2016 San Antonio Breast Cancer Symposium Dec. 6-10. The Orbis Paxman Hair Loss Prevention System, also known as the "Paxman cold cap," consists of a two-cap system; the inner silicon cap contains a circulating refrigerated fluid, while the outer neoprene cap insulates the scalp,
Subscribe or to access all post and page content.